Filing Details
Bioventus Inc. (NASDAQ:BVS) filed a Form 8-K with the Securities and Exchange Commission on August 05, 2026, disclosing a material event.
8k filedNASDAQ:BVS
Bioventus Inc. (BVS) Reports Material Event to SEC
Filing Details Bioventus Inc. (NASDAQ:BVS) filed a Form 8-K with the Securities and Exchange Commission on August 05, 2026, disclosing a material event. Market Context Bioventus…
Market Context
Bioventus Inc.'s stock currently trades at $15.26 with a market capitalization of $495.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Bioventus Inc.'s stock.
All SEC filings for Bioventus Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BVS Stock Page
Frequently Asked Questions
Where can I read BVS's SEC filings?
Browse all filings on our BVS SEC filings page.
What types of SEC filings does Bioventus Inc. file?
Public companies like Bioventus Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.